Year |
Citation |
Score |
2022 |
Menkes MW, Andrews CM, Suzuki T, Chun J, O'Donnell L, Grove T, Deng W, McInnis MG, Deldin PJ, Tso IF. Corrigendum to "Event-related potential correlates of affective response inhibition in bipolar I disorder: Comparison with schizophrenia". [J. Affect. Disord. 309 (2022) 131-140]. Journal of Affective Disorders. PMID 35963782 DOI: 10.1016/j.jad.2022.07.064 |
0.355 |
|
2022 |
Menkes MW, Andrews CM, Suzuki T, Chun J, O'Donnell L, Grove T, Deng W, McInnis MG, Deldin PJ, Tso IF. Event-related potential correlates of affective response inhibition in bipolar I disorder: Comparison with schizophrenia. Journal of Affective Disorders. 309: 131-140. PMID 35472478 DOI: 10.1016/j.jad.2022.04.118 |
0.349 |
|
2020 |
Grove TB, Lasagna CA, Martínez-Cancino R, Pamidighantam P, Deldin PJ, Tso IF. Neural Oscillatory Abnormalities During Gaze Processing in Schizophrenia: Evidence of Reduced Theta Phase Consistency and Inter-areal Theta-Gamma Coupling. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 33160880 DOI: 10.1016/J.Bpsc.2020.08.013 |
0.399 |
|
2020 |
Deng WY, Grove T, Deldin P. Anxiety Mediates the Relationship between Psychotic-Like Experiences and Social Functioning in the General Population. Psychopathology. 53: 95-102. PMID 32623434 DOI: 10.1159/000507869 |
0.357 |
|
2019 |
Kraal AZ, Moll AC, Arvanitis NR, Ward KM, Dougherty RJ, Grove TB, Burghardt KJ, Ellingrod VL. Metabolic syndrome is negatively associated with cognition among endothelial nitric oxide synthase (eNOS)- 786C carriers in schizophrenia-spectrum disorders. Journal of Psychiatric Research. 117: 142-147. PMID 31421598 DOI: 10.1016/J.Jpsychires.2019.07.006 |
0.442 |
|
2019 |
Taylor SF, Grove TB, Ellingrod VL, Tso IF. The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis. Schizophrenia Bulletin. PMID 31150555 DOI: 10.1093/Schbul/Sbz046 |
0.354 |
|
2018 |
Grove TB, Yao B, Mueller SA, McLaughlin M, Ellingrod VL, McInnis MG, Taylor SF, Deldin PJ, Tso IF. A Bayesian model comparison approach to test the specificity of visual integration impairment in schizophrenia or psychosis. Psychiatry Research. 265: 271-278. PMID 29768190 DOI: 10.1016/J.Psychres.2018.04.061 |
0.464 |
|
2017 |
Yao B, Mueller SA, Grove TB, McLaughlin M, Thakkar K, Ellingrod V, McInnis MG, Taylor SF, Deldin PJ, Tso IF. Eye gaze perception in bipolar disorder: Self-referential bias but intact perceptual sensitivity. Bipolar Disorders. PMID 29168603 DOI: 10.1111/Bdi.12564 |
0.43 |
|
2017 |
Tso IF, Grove TB, Mueller SA, O'Donnell L, Chun J, McInnis MG, Deldin PJ. Altered N170 and mood symptoms in bipolar disorder: An electrophysiological study of configural face processing. Bipolar Disorders. PMID 29148147 DOI: 10.1111/Bdi.12587 |
0.366 |
|
2016 |
Grove TB, Burghardt KJ, Kraal AZ, Dougherty RJ, Taylor SF, Ellingrod VL. Oxytocin Receptor (OXTR) Methylation and Cognition in Psychotic Disorders. Molecular Neuropsychiatry. 2: 151-160. PMID 27867940 DOI: 10.1159/000448173 |
0.315 |
|
2016 |
Grove TB, Tso IF, Chun J, Mueller SA, Taylor SF, Ellingrod VL, McInnis MG, Deldin PJ. Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis. Psychiatry Research. 243: 198-206. PMID 27416540 DOI: 10.1016/J.Psychres.2016.06.031 |
0.471 |
|
2015 |
Ellingrod VL, Grove TB, Burghardt KJ, Taylor SF, Dalack G. The effect of folate supplementation and genotype on cardiovascular and epigenetic measures in schizophrenia subjects. Npj Schizophrenia. 1: 15046. PMID 27336047 DOI: 10.1038/npjschz.2015.46 |
0.329 |
|
2015 |
Grove T, Taylor S, Dalack G, Ellingrod V. Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders. Schizophrenia Research. 164: 115-21. PMID 25728832 DOI: 10.1016/J.Schres.2015.02.006 |
0.484 |
|
2014 |
Tso IF, Taylor SF, Grove TB, Niendam T, Adelsheim S, Auther A, Cornblatt B, Carter CS, Calkins R, Ragland JD, Sale T, McFarlane WR. Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program. Early Intervention in Psychiatry. PMID 25529847 DOI: 10.1111/Eip.12209 |
0.338 |
|
2014 |
Tso IF, Grove TB, Taylor SF. Differential hedonic experience and behavioral activation in schizophrenia and bipolar disorder. Psychiatry Research. 219: 470-6. PMID 24999173 DOI: 10.1016/J.Psychres.2014.06.030 |
0.406 |
|
2014 |
Burghardt KJ, Grove TB, Ellingrod VL. Endothelial nitric oxide synthetase genetic variants, metabolic syndrome and endothelial function in schizophrenia Journal of Psychopharmacology. 28: 349-356. PMID 24346810 DOI: 10.1177/0269881113516200 |
0.408 |
|
2014 |
Bly MJ, Taylor SF, Dalack G, Pop-Busui R, Burghardt KJ, Evans SJ, McInnis MI, Grove TB, Brook RD, Zöllner SK, Ellingrod VL. Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population. Bipolar Disorders. 16: 277-88. PMID 24330321 DOI: 10.1111/Bdi.12160 |
0.435 |
|
2014 |
Grove T, Ellingrod V, Taylor S. Poster #M87 FOLATE PHARMACOGENOMICS, ENDOTHELIAL FUNCTIONING, AND NEUROCOGNITION IN SCHIZOPHRENIA SPECTRUM DISORDERS Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70637-1 |
0.448 |
|
2013 |
Lott SA, Burghardt PR, Burghardt KJ, Bly MJ, Grove TB, Ellingrod VL. The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia. The Pharmacogenomics Journal. 13: 264-71. PMID 22391769 DOI: 10.1038/Tpj.2012.6 |
0.312 |
|
2012 |
Burghardt KJ, Pop-Busui R, Bly MJ, Grove TB, Taylor SF, Ellingrod VL. The influence of the brain-derived neurotropic factor Val66Met genotype and HMG-CoA reductase inhibitors on insulin resistance in the schizophrenia and bipolar populations. Clinical and Translational Science. 5: 486-90. PMID 23253673 DOI: 10.1111/Cts.12001 |
0.319 |
|
2012 |
Ellingrod VL, Taylor SF, Dalack G, Grove TB, Bly MJ, Brook RD, Zöllner SK, Pop-Busui R. Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics. Journal of Clinical Psychopharmacology. 32: 261-5. PMID 22370993 DOI: 10.1097/Jcp.0B013E3182485888 |
0.402 |
|
2012 |
Tso IF, Grove TB, Taylor SF. Self-assessment of psychological stress in schizophrenia: Preliminary evidence of reliability and validity. Psychiatry Research. 195: 39-44. PMID 21788084 DOI: 10.1016/J.Psychres.2011.07.009 |
0.38 |
|
2012 |
Wechter A, Gardner KN, Grove TB, Ellingrod VL. Schizophrenia and folate pharmacogenetics: Review of the literature regarding folic acid and its pharmacogenetically regulated metabolism in relation to schizophrenia treatments Mental Health Clinician. 1: 225-229. DOI: 10.9740/Mhc.N99731 |
0.474 |
|
2011 |
Ellingrod VL, Taylor SF, Brook RD, Evans SJ, Zöllner SK, Grove TB, Gardner KM, Bly MJ, Pop-Busui R, Dalack G. Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs). Schizophrenia Research. 130: 20-6. PMID 21504842 DOI: 10.1016/J.Schres.2011.03.031 |
0.443 |
|
2010 |
Tso IF, Grove TB, Taylor SF. Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia. Schizophrenia Research. 122: 156-63. PMID 20051314 DOI: 10.1016/J.Schres.2009.12.007 |
0.403 |
|
Show low-probability matches. |